Heo DS - Search Results

1

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.

Kim M, Keam B, Ock CY, Kim SH, Kim YJ, Lim SM, Kim JS, Kim TM, Hong SH, Ahn MS, Shin SH, Kang EJ, Kim DW, Im SW, Kim JI, Lee JS, Kim JH, Heo DS. Kim M, et al. Among authors: heo ds. Thorac Cancer. 2020 Dec;11(12):3482-3489. doi: 10.1111/1759-7714.13684. Epub 2020 Oct 7. Thorac Cancer. 2020. PMID: 33026712 Free PMC article. Clinical Trial.

2

Colorectal cancer in Korea: characteristics and trends.

Kim DW, Bang YJ, Heo DS, Kim NK. Kim DW, et al. Among authors: heo ds. Tumori. 2002 Jul-Aug;88(4):262-5. doi: 10.1177/030089160208800402. Tumori. 2002. PMID: 12400972

3

Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.

Lee KW, Kim DY, Yun T, Kim DW, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK. Lee KW, et al. Among authors: heo ds. Cancer. 2003 Dec 15;98(12):2651-6. doi: 10.1002/cncr.11846. Cancer. 2003. PMID: 14669285 Free article.

4

Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.

Kim DY, Lee KW, Yun T, Park SR, Jung JY, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK. Kim DY, et al. Among authors: heo ds. Jpn J Clin Oncol. 2003 Dec;33(12):608-12. doi: 10.1093/jjco/hyg118. Jpn J Clin Oncol. 2003. PMID: 14769837

5

Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies.

Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Bang YJ. Kim TY, et al. Among authors: heo ds. Clin Cancer Res. 2004 Jun 1;10(11):3708-16. doi: 10.1158/1078-0432.CCR-03-0655. Clin Cancer Res. 2004. PMID: 15173077 Clinical Trial.

6

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.

Lee JC, Lee KM, Kim DW, Heo DS. Lee JC, et al. Among authors: heo ds. J Immunol. 2004 Jun 15;172(12):7335-40. doi: 10.4049/jimmunol.172.12.7335. J Immunol. 2004. PMID: 15187109

7

Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.

Lee JJ, Kim TM, Yu SJ, Kim DW, Joh YH, Oh DY, Kwon JH, Kim TY, Heo DS, Bang YJ, Kim NK. Lee JJ, et al. Among authors: heo ds. Jpn J Clin Oncol. 2004 Jul;34(7):400-4. doi: 10.1093/jjco/hyh068. Jpn J Clin Oncol. 2004. PMID: 15342667 Clinical Trial.

8

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.

Han SW, Hwang PG, Chung DH, Kim DW, Im SA, Kim YT, Kim TY, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: heo ds. Int J Cancer. 2005 Jan 1;113(1):109-15. doi: 10.1002/ijc.20550. Int J Cancer. 2005. PMID: 15386420 Clinical Trial.

9

Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.

Kim DW, Jo YH, Kim JH, Wu HG, Rhee CS, Lee CH, Kim TY, Heo DS, Bang YJ, Kim NK. Kim DW, et al. Among authors: heo ds. Cancer. 2004 Nov 15;101(10):2257-60. doi: 10.1002/cncr.20648. Cancer. 2004. PMID: 15484215 Free article.

10

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

Park SR, Oh DY, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK, Kang WK, Kim HT, Im SA, Suh JH, Kim HK, Kim HK. Park SR, et al. Among authors: heo ds. Oncol Rep. 2004 Nov;12(5):1059-64. Oncol Rep. 2004. PMID: 15492793 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters